All Updates

All Updates

icon
Filter
Partnerships
Insilico Medicine and NVIDIA launch new biomedical language model Nach0
AI Drug Discovery
May 17, 2024
This week:
Funding
Lhyfe receives EUR 11 million grant from Klimatklivet for green hydrogen project in Sweden
Hydrogen Economy
Yesterday
Product updates
XRAI Glass launches AR One glasses at USD 1449 for hearing-impaired individuals
Extended Reality
Yesterday
Funding
VR therapy platform CUREosity raises EUR 3.8 million in funding to expand market presence
Extended Reality
Yesterday
Last week:
Product updates
Coinbase updates mobile wallet to add decentralized app browser
Decentralized Finance (DeFi)
Jun 22, 2024
Product updates
Coinbase updates mobile wallet to add decentralized app browser
Web3 Ecosystem
Jun 22, 2024
M&A
OpenAI acquires Rockset to power retrieval infrastructure
Data Infrastructure & Analytics
Jun 21, 2024
M&A
OpenAI acquires Rockset to power retrieval infrastructure
Foundation Models
Jun 21, 2024
Partnerships
Product updates
Anthropic releases Claude 3.5 Sonnet, the first model in the 3.5 series
Foundation Models
Jun 21, 2024
Funding
Paramount Planet Product raises USD 1 million in federal grant funding to support commercialization
Bio-based Materials
Jun 21, 2024
Regulation/policy
Apple delays launch of Apple Intelligence features in EU citing regulatory concerns
Generative AI Applications
Jun 21, 2024
AI Drug Discovery

AI Drug Discovery

May 17, 2024

Insilico Medicine and NVIDIA launch new biomedical language model Nach0

Partnerships

  • Hong Kong-based AI drug discovery company Insilico Medicine, in collaboration with NVIDIA, has unveiled a new language processing tool for biomedical and chemical tasks, named nach0. This AI model is designed to solve chemical and biological problems, generate new molecules, and answer biomedical questions.

  • The creators of nach0 claim that the model can bridge the gap between biomedical natural language texts and chemical structure descriptions. It consists of abstract texts extracted from PubMed and chemistry-related patent descriptions taken from the US Patent and Trademark Office (USPTO) as well as molecular structures by the simplified molecular-input line-entry system (SMILES). The model reportedly includes up to 100 million documents and 2.9 billion patent descriptions.

  • The system is built on the NVIDIA BioNeMo generative AI platform for drug discovery applications. The gathered data has been converted into tokens and given unique annotations by the researchers in order to train the system. The training was done using NVIDIA NeMo end-to-end custom generative AI platform, and the datasets were managed by NVIDIA’s memory-mapped data loader modules.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.